Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-22

Clinical Trial Update: Effect of Tesofensine on Weight Reduction in Patients With Obesity. [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating tesofensine for weight loss in obesity has been completed, with results on weight reduction reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tesofensine (tesofensine)

Snippet

Sponsor: NeuroSearch A/S | Conditions: Obesity | Phase 2 | Status: COMPLETED